Tessalyn Morrison,Peter Holck,Tammy L Choromanski,Amy Wilson,Flora Lee,Elizabeth D Ferucci
{"title":"Prevalence of Spondyloarthritis in Alaska Native and American Indian peoples of Alaska.","authors":"Tessalyn Morrison,Peter Holck,Tammy L Choromanski,Amy Wilson,Flora Lee,Elizabeth D Ferucci","doi":"10.3899/jrheum.2025-1105","DOIUrl":null,"url":null,"abstract":"OBJECTIVE\r\nThe objective of this study was to determine the prevalence and clinical characteristics of spondyloarthritis in Alaska Native and American Indian (AN/AI) peoples of Alaska.\r\n\r\nMETHODS\r\nWe queried electronic health records from participating tribal health organizations within the Alaska Tribal Health System from 2012 to 2019 to identify adults with a potential diagnosis of spondyloarthritis based on ICD-9 or ICD-10 codes. Medical records were abstracted to confirm the diagnosis and clinical characteristics. Adults who were alive at the end of the study period and had a confirmed clinician diagnosis of spondyloarthritis were included in prevalence calculations. We determined whether included adults had medical record documentation of meeting spondyloarthritis classification criteria.\r\n\r\nRESULTS\r\nThe age-adjusted prevalence of any form of spondyloarthritis was 355 per 100,000 adults (95% confidence interval (CI) 317-397); for psoriatic arthritis it was 162 (95% CI 137-191) and for ankylosing spondylitis it was 107 (95% CI 86-131). Two-thirds (67.0%) of adults with any form of spondyloarthritis who were tested were HLA B27 positive. Two-thirds of adults with spondyloarthritis other than psoriatic arthritis (69.1%) had documentation in their medical record to confirm that they met clinical classification criteria for axial spondyloarthritis.\r\n\r\nCONCLUSION\r\nThe prevalence of spondyloarthritis in AN/AI peoples of Alaska is lower than previously reported in this population but higher than most populations previously studied Understanding the increased prevalence of spondyloarthritis in this population may help clinicians identify and treat the condition in AN/AI peoples.","PeriodicalId":501812,"journal":{"name":"The Journal of Rheumatology","volume":"19 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3899/jrheum.2025-1105","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
OBJECTIVE
The objective of this study was to determine the prevalence and clinical characteristics of spondyloarthritis in Alaska Native and American Indian (AN/AI) peoples of Alaska.
METHODS
We queried electronic health records from participating tribal health organizations within the Alaska Tribal Health System from 2012 to 2019 to identify adults with a potential diagnosis of spondyloarthritis based on ICD-9 or ICD-10 codes. Medical records were abstracted to confirm the diagnosis and clinical characteristics. Adults who were alive at the end of the study period and had a confirmed clinician diagnosis of spondyloarthritis were included in prevalence calculations. We determined whether included adults had medical record documentation of meeting spondyloarthritis classification criteria.
RESULTS
The age-adjusted prevalence of any form of spondyloarthritis was 355 per 100,000 adults (95% confidence interval (CI) 317-397); for psoriatic arthritis it was 162 (95% CI 137-191) and for ankylosing spondylitis it was 107 (95% CI 86-131). Two-thirds (67.0%) of adults with any form of spondyloarthritis who were tested were HLA B27 positive. Two-thirds of adults with spondyloarthritis other than psoriatic arthritis (69.1%) had documentation in their medical record to confirm that they met clinical classification criteria for axial spondyloarthritis.
CONCLUSION
The prevalence of spondyloarthritis in AN/AI peoples of Alaska is lower than previously reported in this population but higher than most populations previously studied Understanding the increased prevalence of spondyloarthritis in this population may help clinicians identify and treat the condition in AN/AI peoples.
目的:本研究的目的是确定阿拉斯加原住民和美国印第安人(AN/AI)脊柱炎的患病率和临床特征。方法:我们查询了2012年至2019年阿拉斯加部落健康系统内参与部落健康组织的电子健康记录,以根据ICD-9或ICD-10代码识别可能诊断为脊椎关节炎的成年人。提取病历资料以确定诊断和临床特征。在研究期结束时活着并经临床医生确诊为脊柱炎的成年人被纳入患病率计算。我们确定纳入的成年人是否有符合脊柱炎分类标准的医疗记录。结果:任何形式的脊柱炎的年龄校正患病率为每10万成人355例(95%置信区间(CI) 317-397);银屑病关节炎为162 (95% CI 137-191),强直性脊柱炎为107 (95% CI 86-131)。三分之二(67.0%)的成人脊柱炎患者HLA B27阳性。除银屑病关节炎外,三分之二的成人脊柱炎患者(69.1%)在其医疗记录中有文件证明他们符合轴型脊柱炎的临床分类标准。结论阿拉斯加AN/AI人群中脊柱炎的患病率低于先前报道,但高于先前研究的大多数人群。了解该人群中脊柱炎患病率的增加可能有助于临床医生识别和治疗AN/AI人群的疾病。